Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: News and Announcements 2021

February 26, Appendix 4D & Half Year Report

Financial Reports 2021, News and Announcements 2021By PharmAustFebruary 26, 2021

210226_Appendix 4D, half yearly report

February 15, Canine Monepantel Phase IIb Lymphoma Trial Update

News and Announcements 2021By PharmAustFebruary 14, 2021

210215_PhaseIIb_update

February 10, LUMC Covid-19 Research Update

News and Announcements 2021By PharmAustFebruary 10, 2021

210210_LUMC_Update

January 31, Top 20 Shareholders

News and Announcements 2021, Top 20 ShareholdersBy PharmAustFebruary 1, 2021

210131_Top20Shareholders

January 27, Appendix 4C and Quarterly Update

News and Announcements 2021By PharmAustJanuary 27, 2021

210127_Appendix 4C and Quarterly Update

January 22, Epichem Awarded $200k e-Waste Grant

News and Announcements 2021By PharmAustJanuary 22, 2021

210122_Epichem Award

January 9, PAA LUMC COVID-19 Research Update

News and Announcements 2021By PharmAustJanuary 8, 2021

210109_PAA_LUMC Update

12345
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on Twitter PharmAust Retweeted
pharmaust PharmAust @pharmaust ·
25 Jul

PharmAust is pleased to announce that leading Australian broking and corporate advisory firm, @JPEquityPartner, has updated their research coverage on $PAA
 
A full copy of the research note is available for download here 👉 https://www.pharmaust.com/jp-equity-research-report/

Reply on Twitter 1551424206805405699 Retweet on Twitter 1551424206805405699 3 Like on Twitter 1551424206805405699 13 Twitter 1551424206805405699
Load More
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top